CONDENSED INTERIM CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Preferred Stock Series C [Member]	Preferred Stock Series D [Member]	Preferred Stock Series E [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 4	$ 2		$ 15,424	$ 12,456,989	$ (8,198,785)	$ 4,273,634
Balance, beginning (shares) at Dec. 31, 2019	3,501	2,000		15,424,394
Purchase of acquisition				$ (164)	164
Purchase of acquisition (shares)				(164,375)
Sale of Common stock, net of issuance costs				$ 6,807	12,889,935		12,896,742
Sale of Common stock, net of issuance costs (shares)				6,807,400
Sale of Common stock from conversion of pre-paid warrants				$ 3,260	7		3,267
Sale of Common stock from conversion of pre-paid warrants (shares)				3,260,377
Issuance of Common stock for consulting services				$ 250	297,250		297,500
Issuance of Common stock for consulting services (shares)				250,000
Conversion of Series C Preferred stock	$ (4)			$ 13,634	(13,594)
Conversion of Series C Preferred stock (shares)	(3,501)			13,597,984
Conversion of Series D Preferred stock and accrued dividends		$ (2)		$ 3,500	160,057		163,555
Conversion of Series D Preferred stock and accrued dividends (shares)		(1,890)		3,500,000
Conversion of Series D warrants				$ 2,948	(2,948)
Conversion of Series D warrants (shares)				2,947,739
Issuance of Series E Preferred Stock, net of issuance costs			$ 1		1,009,999		1,010,000
Issuance of Series E Preferred Stock, net of issuance costs, shares			1,050
Repurchase of Series E Preferred stock					(1,110,880)		(1,110,880)
Repurchase of Series E Preferred stock, Shares			(262)
Conversion of Series E Preferred stock			$ (1)	$ 3,152	(3,151)
Conversion of Series E Preferred stock (shares)			(788)	3,152,000
Deemed dividend on Series C Preferred stock and Series D warrants					4,050,838	(4,050,838)
Deemed dividend on redemption of Series D Preferred stock					3,763,591	(3,763,591)
Exercise of options				$ 34	(34)
Exercise of options (shares)				33,758
Stock-based compensation expense				$ 170	139,387		139,557
Stock-based compensation expense (shares)				170,000
Net loss						(1,658,641)	(1,658,641)
Ending balance, value at Jun. 30, 2020				$ 48,979	33,637,610	(17,671,855)	16,014,734
Balance, ending (shares) at Jun. 30, 2020		110		48,979,277
Beginning balance, value at Mar. 31, 2020	$ 3	$ 2		$ 15,610	12,470,994	(8,602,058)	3,884,551
Balance, beginning (shares) at Mar. 31, 2020	3,312	2,000		15,610,019
Sale of Common stock, net of issuance costs				$ 6,807	12,889,935		12,896,742
Sale of Common stock, net of issuance costs (shares)				6,807,400
Sale of Common stock from conversion of pre-paid warrants				$ 3,260	7		3,267
Sale of Common stock from conversion of pre-paid warrants (shares)				3,260,377
Issuance of Common stock for consulting services				$ 250	297,250		297,500
Issuance of Common stock for consulting services (shares)				250,000
Conversion of Series C Preferred stock	$ (3)			$ 13,248	(13,245)
Conversion of Series C Preferred stock (shares)	(3,312)			13,247,984
Conversion of Series D Preferred stock and accrued dividends		$ (2)		$ 3,500	200,502		204,000
Conversion of Series D Preferred stock and accrued dividends (shares)		(1,890)		3,500,000
Conversion of Series D warrants				$ 2,948	(2,948)
Conversion of Series D warrants (shares)				2,947,739
Issuance of Series E Preferred Stock, net of issuance costs			$ 1		1,009,999		1,010,000
Issuance of Series E Preferred Stock, net of issuance costs, shares			1,050
Repurchase of Series E Preferred stock					(1,110,880)		(1,110,880)
Repurchase of Series E Preferred stock, Shares			(262)
Conversion of Series E Preferred stock			$ (1)	$ 3,152	(3,151)
Conversion of Series E Preferred stock (shares)			(788)	3,152,000
Deemed dividend on Series C Preferred stock and Series D warrants					4,050,838	(4,050,838)
Deemed dividend on redemption of Series D Preferred stock					3,763,591	(3,763,591)
Exercise of options				$ 34	(34)
Exercise of options (shares)				33,758
Stock-based compensation expense				$ 170	84,752		84,922
Stock-based compensation expense (shares)				170,000
Net loss						(1,255,368)	(1,255,368)
Ending balance, value at Jun. 30, 2020				$ 48,979	33,637,610	(17,671,855)	16,014,734
Balance, ending (shares) at Jun. 30, 2020		110		48,979,277
Beginning balance, value at Dec. 31, 2020				$ 58,636	47,241,757	(20,945,664)	26,354,729
Balance, beginning (shares) at Dec. 31, 2020				58,636,365
Sale of Common stock, net of issuance costs				$ 6,328	34,954,776		34,961,104
Sale of Common stock, net of issuance costs (shares)				6,328,314
Sale of Common Stock from exercise of warrants				$ 2,517	8,302,851		8,305,368
Sale of Common Stock from exercise of warrants, shares				2,516,778
Issuance of Common stock for acquisition of MicaSense				$ 541	2,999,459		3,000,000
Issuance of Common stock for acquisition of MicaSense, shares				540,541
Issuance of Common stock for acquisition of Measure				$ 5,319	24,369,681		24,375,000
Issuance of Common stock for acquisition of Measure, shares				5,319,145
Stock issued in exchange for professional services				$ 550	2,906,450		2,907,000
Stock issued in exchange for professional services, shares				550,000
Exercise of options				$ 407	75,418		75,825
Exercise of options (shares)				406,015
Stock-based compensation expense				$ 371	2,527,279		2,527,650
Stock-based compensation expense (shares)				371,402
Net loss						(7,608,702)	(7,608,702)
Ending balance, value at Jun. 30, 2021				$ 74,669	123,377,671	(28,554,366)	94,897,974
Balance, ending (shares) at Jun. 30, 2021				74,668,560
Beginning balance, value at Mar. 31, 2021				$ 62,501	62,344,452	(23,876,194)	38,530,759
Balance, beginning (shares) at Mar. 31, 2021				62,500,815
Sale of Common stock, net of issuance costs				$ 5,271	28,641,890		28,647,161
Sale of Common stock, net of issuance costs (shares)				5,271,100
Issuance of Common stock for acquisition of MicaSense				$ 541	2,999,459		3,000,000
Issuance of Common stock for acquisition of MicaSense, shares				540,541
Issuance of Common stock for acquisition of Measure				$ 5,319	24,369,681		24,375,000
Issuance of Common stock for acquisition of Measure, shares				5,319,145
Stock issued in exchange for professional services				$ 550	2,906,450		2,907,000
Stock issued in exchange for professional services, shares				550,000
Exercise of options				$ 131	34,314		34,445
Exercise of options (shares)				130,557
Stock-based compensation expense				$ 356	2,081,425		2,081,781
Stock-based compensation expense (shares)				356,402
Net loss						(4,678,172)	(4,678,172)
Ending balance, value at Jun. 30, 2021				$ 74,669	$ 123,377,671	$ (28,554,366)	$ 94,897,974
Balance, ending (shares) at Jun. 30, 2021				74,668,560